Speaker illustration

Professor Tetsuya Hayashi

Osaka Medical College, Takatsuki (Japan)

Rivaroxaban combined with spironolactone attenuates cardiovascular remodeling due to hypoxia in pulmonary arterial hypertension

Event: ESC Congress 2018

Topic: Anticoagulants

Session: Best Posters in cardiovascular remodelling

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb